F11a and FX12a Inhibitors – the Next Wave of Novel Anticoagulants?​

Anticoagulation treatment has been revolutionised in the past few decades with the development of drugs that increasingly target individual components of the coagulation cascade. Yet the quest to find improved solutions that prevent thrombosis without causing too much bleeding, particularly in patients at higher risk, continues.   During the ‘Back to the Future’ session, Sarah […]

Time is Right for Restrictive Transfusion Strategy in ECMO

Despite studies supporting a restrictive red cell transfusion strategy in many medical situations, a more liberal strategy is still widely used in patients who need extracorporeal membrane oxygenation (ECMO), Alexander Vlaar (Amsterdam UMC, The Netherlands) highlighted during ‘The Heart of Anaemia’ session.   The time has come to question the preponderance of the liberal strategy […]